Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05576090 · ClinicalTrials.gov registry record · NA

UCLA REST Study (REsearch on Sleep Techniques)

A NA study of Inflammation and Sleep Disturbance, sponsored by University of California, Los Angeles.

Recruiting
Registry status
NA
Development phase
240
Enrollment target
1
Study location

NCT05576090 is a NA study of Inflammation and Sleep Disturbance that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 240 participants, below the 286-participant average among 132 other Inflammation trials with a reported enrollment target (16% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05576090, a NA study of Inflammation and Sleep Disturbance, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
1
Study location

Study Summary

Sleep disturbance has a range of negative effects on psychosocial and biological processes important for academic and social success as well as mental and physical health among adolescents and young adults. Limited, inconsistent, and poor quality sleep lead to anxiety, depressive feelings, loneliness, and fatigue over time. These symptoms, in turn, interfere with the ability to get a good night's rest. Sleep disruption can also upregulate inflammatory processes during the years of adolescence and young adulthood in ways that can create risk for the development of chronic health conditions (e.g., diabetes, depression, cardiovascular disease) in later adulthood. Sleep, however, is also a modifiable health behavior, leading many institutions to embark upon efforts to improve the sleep of their students. The challenge is to identify programs and interventions that can simultaneously improve sleep, be delivered at scale, and be easily completed by students. UCLA has developed and validated a group-based mindfulness intervention, Mindful Awareness Practices (MAPs), that has demonstrated beneficial effects on sleep in adults and may offer a promising, scalable approach for reducing sleep disturbance and improving associated psychological and biological outcomes in college students. However, this approach requires validation in this population relative to sleep education programs, which increasingly dominate the college landscape. To address this important public health problem, the investigators propose to conduct a single site, two-arm, parallel group randomized controlled trial to test the efficacy of the validated, group-based, six-week MAPs intervention vs. sleep education, an active time and attention matched control condition, for first and second year undergraduate students who report poor sleep at this critical transition year. The investigators are aiming to enroll approximately 240 participants. Participants will complete questionnaires, provide blood samples for

Interventions

  • BEHAVIORAL Sleep Education
  • BEHAVIORAL Mindfulness Meditation

Study Locations (1)

California

  • University of California, Los Angeles - Los Angeles

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2023-04-03
Est. Completion 2027-06-30
Phase NA

What the Registry Record Tells You About NCT05576090

The ClinicalTrials.gov registry entry for NCT05576090 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 286-participant average among 132 other Inflammation trials with a reported enrollment target (16% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Inflammation appearing as the primary indexed condition, and to 2 interventions - of which Sleep Education is the first listed.

NCT05576090 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05576090 about?

NCT05576090 is a clinical study titled "UCLA REST Study (REsearch on Sleep Techniques)". Sleep disturbance has a range of negative effects on psychosocial and biological processes important for academic and social success as well as mental and physical health among adolescents and young adults. Limited, inconsistent, and poor quality sleep lead to anxiety, depressive feelings, lonelines...

What is the current status of trial NCT05576090?

This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2023-04-03. Estimated completion is 2027-06-30.

What conditions does trial NCT05576090 study?

This clinical trial studies the following conditions: Inflammation, Sleep Disturbance, Psychosocial Functioning.

What interventions are being tested in trial NCT05576090?

The interventions under investigation include: Sleep Education (BEHAVIORAL), Mindfulness Meditation (BEHAVIORAL).

Who is sponsoring clinical trial NCT05576090?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05576090 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.